Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jean, S.-S. | - |
dc.contributor.author | Hsueh, P.-R. | - |
dc.contributor.author | Korman, T. | - |
dc.contributor.author | Ellem, J. | - |
dc.contributor.author | George, N. | - |
dc.contributor.author | Coombs, G. | - |
dc.contributor.author | Ling, T. | - |
dc.contributor.author | Tsang, O. | - |
dc.contributor.author | Balaji, V. | - |
dc.contributor.author | Mikamo, H. | - |
dc.contributor.author | Kusachi, S. | - |
dc.contributor.author | Mizutani, T. | - |
dc.contributor.author | Kim, M.-J. | - |
dc.contributor.author | Bae, I.-G. | - |
dc.contributor.author | Umur, N.B. | - |
dc.contributor.author | Rajasekaram, D.G. | - |
dc.contributor.author | Taylor, S. | - |
dc.contributor.author | Roberts, S. | - |
dc.contributor.author | van, der Werff K. | - |
dc.contributor.author | Drinkovic, D. | - |
dc.contributor.author | Lagamayo, E. | - |
dc.contributor.author | Mendoza, M. | - |
dc.contributor.author | Tan, T.Y. | - |
dc.contributor.author | Krishnan, P. | - |
dc.contributor.author | Wang, E. | - |
dc.contributor.author | Lu, P.-L. | - |
dc.contributor.author | Liu, C.-E. | - |
dc.contributor.author | Chuang, K.Y.-C. | - |
dc.contributor.author | Yu, K.-W. | - |
dc.contributor.author | Chen, Y.-S. | - |
dc.contributor.author | Lu, M.-C. | - |
dc.contributor.author | Panthuwong, S. | - |
dc.contributor.author | Kiratisin, P. | - |
dc.contributor.author | Phoung, N.T.M. | - |
dc.contributor.author | Phuong, D.M. | - |
dc.contributor.author | Van, N.T. | - |
dc.contributor.author | Nga, T.T.T. | - |
dc.contributor.author | SMART Asia-Pacific Group | - |
dc.date.accessioned | 2021-09-03T14:06:08Z | - |
dc.date.available | 2021-09-03T14:06:08Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 0305-7453 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/86117 | - |
dc.description.abstract | Objectives: To investigate the antimicrobial resistance and assess the molecular characteristics of β-lactamases (ESBLs, AmpC β-lactamases and carbapenemases) among Enterobacteriaceae isolates that caused intraabdominal infections (IAIs) in patients hospitalized in the Asia-Pacific region during 2008-14. Methods: Multiplex PCR was used to detect the specific types of β-lactamase in 2893 isolates with MICs of ertapenem.0.5 mg/L. In-hospital acquisition times for most isolates were also delineated. Results: Among 2728 (94.3%) isolates proven with β-lactamase production, the rates of non-susceptibility to imipenem were low (average=7.9%) among IAI Enterobacteriaceae isolates from all Asia-Pacific countries except Vietnam (17.7%) and the Philippines (10.2%). A stepwise and significant increase in annual rates of carbapenemase production among these isolates was noted. CTX-M-15 and CTX-M-14 were the dominant ESBL variants in most IAI Enterobacteriaceae species. The most abundant AmpC β-lactamase variants were blaCMY-2 among isolates of Escherichia coli and blaDHA-1 among isolates of Klebsiella pneumoniae. In addition, the IAI Enterobacteriaceae isolates harbouring a blaCMY-2 or blaDHA-1 allele were associated with high communityacquired rates (38.0% and 42.6%, respectively). AmpC ACT and MIR variants were mostly detected in Enterobacter species. The blaNDM-1,4,5,7-harbouring isolates of E. coli, K. pneumoniae and Enterobacter cloacae were most commonly identified among IAI isolates from Vietnam and the Philippines. Also of note, blaOXA-48- harbouring IAI Enterobacteriaceae isolates were detected exclusively in Vietnam. Conclusions: The high resistance burden in Vietnam and the Philippines warrants aggressive control policies to combat the worsening trend in antimicrobial resistance among Enterobacteriaceae species causing IAIs. © The Author 2016. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Oxford University Press | - |
dc.subject | amikacin | - |
dc.subject | beta lactamase | - |
dc.subject | beta lactamase AmpC | - |
dc.subject | carbapenemase | - |
dc.subject | cefoxitin | - |
dc.subject | ceftriaxone | - |
dc.subject | ciprofloxacin | - |
dc.subject | ertapenem | - |
dc.subject | extended spectrum beta lactamase | - |
dc.subject | imipenem | - |
dc.subject | levofloxacin | - |
dc.subject | piperacillin plus tazobactam | - |
dc.subject | antiinfective agent | - |
dc.subject | beta lactam | - |
dc.subject | beta lactamase | - |
dc.subject | abdominal infection | - |
dc.subject | antibiotic resistance | - |
dc.subject | antibiotic sensitivity | - |
dc.subject | Article | - |
dc.subject | Asia | - |
dc.subject | bacterium detection | - |
dc.subject | bacterium isolate | - |
dc.subject | Enterobacter cloacae | - |
dc.subject | Enterobacteriaceae | - |
dc.subject | enzyme localization | - |
dc.subject | Escherichia coli | - |
dc.subject | geographic distribution | - |
dc.subject | human | - |
dc.subject | Klebsiella pneumoniae | - |
dc.subject | minimum inhibitory concentration | - |
dc.subject | multiplex polymerase chain reaction | - |
dc.subject | nonhuman | - |
dc.subject | Pacific islands | - |
dc.subject | Philippines | - |
dc.subject | urinary tract infection | - |
dc.subject | Viet Nam | - |
dc.subject | classification | - |
dc.subject | Enterobacteriaceae | - |
dc.subject | Enterobacteriaceae infection | - |
dc.subject | enzymology | - |
dc.subject | epidemiological monitoring | - |
dc.subject | genetics | - |
dc.subject | isolation and purification | - |
dc.subject | microbial sensitivity test | - |
dc.subject | microbiology | - |
dc.subject | urinary tract infection | - |
dc.subject | Anti-Bacterial Agents | - |
dc.subject | Asia | - |
dc.subject | beta-Lactamases | - |
dc.subject | beta-Lactams | - |
dc.subject | Drug Resistance, Bacterial | - |
dc.subject | Enterobacteriaceae | - |
dc.subject | Enterobacteriaceae Infections | - |
dc.subject | Epidemiological Monitoring | - |
dc.subject | Humans | - |
dc.subject | Microbial Sensitivity Tests | - |
dc.subject | Multiplex Polymerase Chain Reaction | - |
dc.subject | Pacific Islands | - |
dc.subject | Urinary Tract Infections | - |
dc.title | Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, M.-J. | - |
dc.identifier.doi | 10.1093/jac/dkw398 | - |
dc.identifier.scopusid | 2-s2.0-85014571133 | - |
dc.identifier.bibliographicCitation | Journal of Antimicrobial Chemotherapy, v.72, no.1, pp.166 - 171 | - |
dc.relation.isPartOf | Journal of Antimicrobial Chemotherapy | - |
dc.citation.title | Journal of Antimicrobial Chemotherapy | - |
dc.citation.volume | 72 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 166 | - |
dc.citation.endPage | 171 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | amikacin | - |
dc.subject.keywordPlus | beta lactamase | - |
dc.subject.keywordPlus | beta lactamase AmpC | - |
dc.subject.keywordPlus | carbapenemase | - |
dc.subject.keywordPlus | cefoxitin | - |
dc.subject.keywordPlus | ceftriaxone | - |
dc.subject.keywordPlus | ciprofloxacin | - |
dc.subject.keywordPlus | ertapenem | - |
dc.subject.keywordPlus | extended spectrum beta lactamase | - |
dc.subject.keywordPlus | imipenem | - |
dc.subject.keywordPlus | levofloxacin | - |
dc.subject.keywordPlus | piperacillin plus tazobactam | - |
dc.subject.keywordPlus | antiinfective agent | - |
dc.subject.keywordPlus | beta lactam | - |
dc.subject.keywordPlus | beta lactamase | - |
dc.subject.keywordPlus | abdominal infection | - |
dc.subject.keywordPlus | antibiotic resistance | - |
dc.subject.keywordPlus | antibiotic sensitivity | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | Asia | - |
dc.subject.keywordPlus | bacterium detection | - |
dc.subject.keywordPlus | bacterium isolate | - |
dc.subject.keywordPlus | Enterobacter cloacae | - |
dc.subject.keywordPlus | Enterobacteriaceae | - |
dc.subject.keywordPlus | enzyme localization | - |
dc.subject.keywordPlus | Escherichia coli | - |
dc.subject.keywordPlus | geographic distribution | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | Klebsiella pneumoniae | - |
dc.subject.keywordPlus | minimum inhibitory concentration | - |
dc.subject.keywordPlus | multiplex polymerase chain reaction | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | Pacific islands | - |
dc.subject.keywordPlus | Philippines | - |
dc.subject.keywordPlus | urinary tract infection | - |
dc.subject.keywordPlus | Viet Nam | - |
dc.subject.keywordPlus | classification | - |
dc.subject.keywordPlus | Enterobacteriaceae | - |
dc.subject.keywordPlus | Enterobacteriaceae infection | - |
dc.subject.keywordPlus | enzymology | - |
dc.subject.keywordPlus | epidemiological monitoring | - |
dc.subject.keywordPlus | genetics | - |
dc.subject.keywordPlus | isolation and purification | - |
dc.subject.keywordPlus | microbial sensitivity test | - |
dc.subject.keywordPlus | microbiology | - |
dc.subject.keywordPlus | urinary tract infection | - |
dc.subject.keywordPlus | Anti-Bacterial Agents | - |
dc.subject.keywordPlus | Asia | - |
dc.subject.keywordPlus | beta-Lactamases | - |
dc.subject.keywordPlus | beta-Lactams | - |
dc.subject.keywordPlus | Drug Resistance, Bacterial | - |
dc.subject.keywordPlus | Enterobacteriaceae | - |
dc.subject.keywordPlus | Enterobacteriaceae Infections | - |
dc.subject.keywordPlus | Epidemiological Monitoring | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Microbial Sensitivity Tests | - |
dc.subject.keywordPlus | Multiplex Polymerase Chain Reaction | - |
dc.subject.keywordPlus | Pacific Islands | - |
dc.subject.keywordPlus | Urinary Tract Infections | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.